{"disease":{"id":"limb-girdle-muscular-dystrophy-type-2d-r3","name":"limb girdle muscular dystrophy type 2d r3"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06747273","title":"Study to Evaluate the Safety, Tolerability, and Efficacy of SRP-9004 Administered by Systemic Infusion in Limb Girdle Muscular Dystrophy Type 2D/R3 Participants in the United States","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Sarepta Therapeutics, Inc.","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}